Paradeep Phosphates (PARADEEP) Q2 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 25/26 earnings summary
19 Dec, 2025Executive summary
Q2 and H1 FY26 delivered strong operational and financial performance, highlighted by the completed merger with MCFL, which increased production capacity by 23% to 3.7 million MT and expanded national market presence.
Major capex projects totaling INR 3,600 crore were approved for granulation and acid plants at Paradeep and Mangalore, targeting 5.0 MMTPA sales and full backward integration within 2.5 years.
The integration broadens market presence, enhances customer access, and unlocks synergies in procurement, logistics, and product mix.
Appointed Rahul Dravid as brand ambassador and new board members to strengthen brand and governance.
Financials restated retrospectively to include MCFL from April 1, 2024, as per NCLT-approved scheme.
Financial highlights
Q2 FY26 revenue from operations rose 49% YoY to INR 6,872 crore; EBITDA grew 32% to INR 698 crore (margin 10.1%); PAT increased 34% to INR 342 crore.
H1 FY26 net profit rose 134.7% YoY to ₹6,587 million, with EBITDA up 69.3% YoY to ₹13,131 million.
Cash conversion cycle improved by 30 days to 58 days; net debt to equity at 0.66.
Basic EPS for H1 FY26 at ₹6.35, up 134.3% YoY.
Standalone and consolidated financials reflect the amalgamation of MCFL from April 1, 2024.
Outlook and guidance
Major capacity expansions at Paradeep and Mangalore to be completed within 2.5 years, aiming for 100% backward integration and reduced import dependency.
Targeting 5.0 MMTPA sales by FY28 through capacity expansion and backward integration.
Strategic priorities include scale efficiency, product innovation, and sustainability.
Full capacity from new investments expected to be operational by end of FY28, with peak capacity in FY29.
Latest events from Paradeep Phosphates
- Profitability improved despite lower Q1 volumes; new launches and merger progress support outlook.PARADEEP
Q1 24/259 Feb 2026 - Revenue and profit soared on higher volumes, MCFL merger, and expansion, with strong outlook.PARADEEP
Q3 25/264 Feb 2026 - Q3 FY25 delivered strong revenue and profit growth, with expansion and merger plans advancing.PARADEEP
Q3 24/2519 Dec 2025 - Record profit and sales growth, strong cash flow, and capacity expansion ahead.PARADEEP
Q4 24/2519 Dec 2025 - Q1 FY26 saw 58% revenue growth, margin expansion, and MCFL merger progress.PARADEEP
Q1 25/2619 Dec 2025 - Q2 FY25 profit soared 155% YoY, with major phosphoric acid expansion approved.PARADEEP
Q2 24/2519 Dec 2025